Sirolimus has anti-skin cancer effect in kidney transplant patients News-Medical.net Switching from calcineurin inhibitors (tacrolimus and cyclosporin) to a sirolimus-containing immunosuppression regimen may help reduce the incidence of secondary skin cancer after kidney transplantation, suggests research published in TheNew England ... |
